Skip to main content

Table 2 EDSS scores in each month during the study period

From: The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

EDSS scores

Groups

Mean

Standard deviation

Minimum

Maximum

F

Sig

Month 1

Study

5.45

0.15

5

5.5

14.46

0.00

Control

4.52

1.09

3

6

Month 2

Study

5.45

0.15

5

5.5

14.46

0.00

Control

4.52

1.09

3

6

Month 3

Study

5.45

0.39

5.4

6

11.93

0.00

Control

4.55

1.12

3

6.5

Month 4

Study

5.25

0.55

4

6

5.38

0.03

Control

4.63

1.10

3

6.5

Month 5

Study

5.10

0.68

4

6

0.99

0.33

Control

4.83

1.06

3

6.5

Month 6

Study

4.95

0.74

3

6

0.13

0.72

Control

4.85

1.08

3

6.5

Month 7

Study

4.85

0.75

3

5.5

1.00

0.96

Control

4.87

1.15

3

7

Month 8

Study

4.63

0.94

3

6

1.30

0.26

Control

4.97

1.10

3

7

Month 9

Study

455

0.93

3

6

3.74

0.06

Control

5.13

1.11

3.5

7

Month 10

Study

4.33

1.12

2.5

6

6.35

0.02

Control

5.15

1.15

3

7

Month 11

Study

4.13

1.35

2

6

7.63

0.01

Control

5.12

1.17

3

7

Month 12

Study

3.98

1.37

2

6

9.54

0.00

Control

5.10

1.18

3

7